Pulse Oximeter Market Forecasts to 2030 - Global Analysis By Product (Sensors, Equipment and Other Products), Type, Age Group, Technology, End User and By Geography

According to Stratistics MRC, the Global Pulse Oximeter Market is accounted for $2.6 billion in 2023 and is expected to reach $5.5 billion by 2030 growing at a CAGR of 11.4% during the forecast period. A piece of medical equipment called a pulse oximeter examines the level of oxygen in a patient's blood. It is a tiny clip-like instrument that, when externally linked to a person's finger, toe, or earlobe, measures when and how much oxygen is being used up. People's pulses are regularly checked in hospital wards during procedures, crises, treatments, and recovery. The instrument sends light through the point of contact and measures how much can flow to the other end in order to calculate the amount of oxygen in red blood cells.

According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes. Total number of people living with diabetes is projected to rise to 643 million by 2045.

Market Dynamics:

Driver:

Expansion of medical device companies in emerging economies

Players in the pulse oximeter market for medical devices are likely experiencing tremendous development potential due to emerging economies. Governments in countries like China and India are consistently increasing their expenditures on value-based care and healthcare modernization. Additionally, manufacturing hubs for medical equipment and generic medications are emerging in emerging nations.

Restraint:

Emergence of alternative smart device technologies

Companies that are placing a greater emphasis on health technology are currently challenging the traditional market. Smartwatches with sensors that track SpO2 levels in the blood are now available on the market, along with other capabilities like heart rate and pulse rate monitoring and routine energy consumption. The development of the pulse oximeter market will therefore be hampered in the coming years by the availability of substitute oximetry devices.

Opportunity:

Increasing incidence of respiratory diseases

Among the most common respiratory illnesses worldwide are pneumonia, asthma, and chronic obstructive pulmonary disease (COPD). The lungs' airways get clogged in conditions including COPD, asthma, and pneumonia, making it challenging to breathe in and out and finally resulting in low blood oxygen levels. Patients who experience hypoxia as a result of COPD, asthma, or pneumonia require oxygen therapy. The noninvasive test of pulse oximetry measures oxygen saturation in individuals who are critically unwell and have trouble inhaling. The amount detected and displayed on the pulse oximeter's screen corresponds to the oxygenation of red blood cells.

Threat:

Regulations and accuracy concerns for OTC pulse oximeters

"OTC" medical items are those that have been approved by the appropriate medical authorities for direct sale to consumers without a prescription. OTC pulse oximeters do not require FDA approval and can be purchased without a prescription from any pharmacy. However, there are issues with the reliability and safety of over-the-counter pulse oximeters.

COVID-19 Impact:

During the analysis period, it is anticipated that COVID-19's impact will cause the market to grow by significant amounts. This is due to a drop in in-person visits to healthcare facilities and a considerable rise in the deployment of fingertip pulse oximeters, both of which are supported by favorable regulations. Low oxygen saturation levels in the patients were caused by the rise of severe COVID-19 cases, which increased the demand for ongoing care of critically ill patients. According to a study that appeared in the Hindustan Times in 2021, approximately 40% of COVID-19 patients hospitalized at AIIMS Jhajjar in India had oxygen saturation levels below 94% when they were admitted. The market size significantly increased as a result of COVID-19 patients' declining oxygen saturation levels and growing government support for using these products to continuously monitor oxygen levels.

The disposable sensor segment is expected to be the largest during the forecast period

the disposable sensor segment held the largest market share during the anticipated period, due to its potential for non-invasive monitoring and its lightweight nature for greater patient satisfaction. Furthermore, disposable sensors are outstanding and well-suited for long-term monitoring due to their great flexibility and the biocompatibility of the soft material used. Disposable sensor oximeters' improved capacity to stop HAIs and cross-contamination has further accelerated their use. Among the pioneers in the provision of disposable sensors is Honeywell International Inc.

The adult segment is expected to have the highest CAGR during the forecast period

Owing to the increased prevalence of chronic respiratory diseases, including COPD and asthma, in the adult population as well as the rising number of adult hospitalizations necessitating ongoing patient monitoring, the adult segment is predicted to experience profitable growth over the course of the projected period. Additionally, the large increase in the elderly population has increased demand for pulse oximeters because monitoring vital indicators like SpO2 is essential for the elderly population.

Region with largest share:

Due to an increase in new products and regulatory approvals, North America held the majority of the market share. Additionally, the region's growth is being fueled by the rising prevalence of respiratory disorders and the presence of cutting-edge healthcare infrastructure in the area. Moreover, the market in the region is expected to be driven by the rapid adoption of wireless pulse oximeters and the growing use of oximeters in home healthcare and also by presence of a technologically proficient healthcare system and an increase in hospital admissions because of the high disease burden.

Region with highest CAGR:

Owing to the high prevalence of chronic diseases there, the Asia-Pacific area is anticipated to develop at the highest rate. Furthermore, a large population, increased income levels, and increased patient awareness of cutting-edge pulse oximeters would all contribute to further market expansion. Additionally, factors promoting regional expansion include the high frequency of target diseases, advancements in healthcare infrastructure, and growing public knowledge of effective patient monitoring technologies.

Key players in the market:

Some of the key players in Pulse Oximeter market include: GE Healthcare , Dragerwerk AG & Co. KGaA, General Electric, ICU Medical, Inc., Koninklijke Philips N.V., Masimo, Medtronic, NIHON KOHDEN CORPORATION, Nonin and OSI Systems, Inc.

Key Developments:

In June 2022, the Garmin Vivosmart 5 fitness band was introduced in India. The new fitness tracker features blood oxygen level monitoring, step counting, calorie counting, stress tracking, heart rate monitoring, body battery energy monitoring, and women's health tracking.

In December 2021, Telli Health announced the delivery of its first U.S. FDA certified and approved 4G cellular-connected SpO2 oximeter. This oximeter and its remote patient monitoring devices help track the COVID-19 patients during the pandemic.

Products Covered:

• Sensors
• Equipment
• Other Products

Types Covered:

• Bedside/ Tabletop Pulse Oximeters
• Portable Pulse Oximeters
• Other Types

Age Groups Covered:

• Pediatric
• Adult

Technologies Covered:

• Connected Devices
• Conventional Devices
• Other Technologies

End Users Covered:

• Ambulatory Care Settings
• Home Care Settings
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances